Kalkitoxin

Last updated
Kalkitoxin
Kalkitoxin.svg
Names
Preferred IUPAC name
(2R)-N-{(3S,5S,6R)-7-[(4R)-4-Ethenyl-4,5-dihydro-1,3-thiazol-2-yl]-3,5,6-trimethylheptyl}-N,2-dimethylbutanamide
Identifiers
3D model (JSmol)
ChemSpider
PubChem CID
UNII
  • InChI=1S/C21H38N2OS/c1-8-16(4)21(24)23(7)11-10-15(3)12-17(5)18(6)13-20-22-19(9-2)14-25-20/h9,15-19H,2,8,10-14H2,1,3-7H3/t15-,16-,17+,18-,19-/m1/s1
    Key: PHYRFZDJEDWWKT-UJWQCDCRSA-N
  • CC[C@@H](C)C(=O)N(C)CC[C@@H](C)C[C@H](C)[C@H](C)CC1=N[C@@H](CS1)C=C
Properties
C21H38N2OS
Molar mass 366.61 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Kalkitoxin, a toxin derived from the cyanobacterium Lyngbya majuscula , induces NMDA receptor mediated neuronal necrosis, blocks voltage-dependent sodium channels, and induces cellular hypoxia by inhibiting the electron transport chain (ETC) complex 1.

Contents

Natural sources

Kalkitoxin is an ichthyotoxin, derived from the cyanobacterium Lyngbya majuscula [1] which covers sections of the coral reef. [2] It typically forms mini-blooms [2] and produces several metabolites, such as kalkitoxin, curacin-A and antillatoxin. [1] Kalkitoxin has been found and purified near the coasts of Curaçao [1] and Puerto Rico. [3]

Structure and reactivity

Kalkitoxin is a lipopeptide toxin [4] with a molecular weight of 366.604Da. [5] Its chemical formula is C21H38N2OS. [6] The structure contains two double bonds, a 2,4-disubstituted thiazoline ring system, and an additional carbonyl-group. [6] These four groups each provide a degree of unsaturation, which causes kalkitoxin to have four degrees of unsaturation. [6] The structure contains 5 chiral centers, one of which is due to a substituent of the thiazoline ring, and the other four are due to methine groups along the aliphatic carbon chain, [7] which are tertiary carbon atoms bearing three single carbon bonds and one hydrogen. The four methyl groups (each at a methine chiral center), the structure's overall stereochemistry, and the N-methyl group all contribute to the toxicity of kalkitoxin. [7]

The six partial structures used to derive the total structure of kalkitoxin Partial Structures.jpg
The six partial structures used to derive the total structure of kalkitoxin

Structure determination

The structure of kalkitoxin was first determined by characterizing six partial structures which were subsequently connected to yield the total structure. [4] This investigation was largely carried out through various NMR experiments. Structure (a) is a sec-butyl group, indicated by characteristic deshielding of its central methine group due to the adjacent carbonyl. Structure (b) contains this carbonyl group, and an adjacent tertiary methylated nitrogen atom, constituting a tertiary amide group. Since this is a tertiary amide, it exists in a cis/trans mixture, which underlies the two conformations of kalkitoxin. Structure (c) is a string of two methylene groups, then a methine group bearing a high-field methyl group. The next two groups identified (d,e) are identical and opposing strings of CH2-CH-CH3, however the left grouping's methylene protons experience greater deshielding, due to their proximity to the adjacent imine. Deshielding is an effect of a nearby electronegative atom withdrawing electron density from a given atom nucleus, eliciting an increased chemical shift as measured by NMR.

The final partial structure consists of a thiazoline ring with a terminal alkene substituent, as determined by electron ionization mass spectrometry (EI-MS) and 13C NMR. [4] The chemical shifts of ring carbons adjacent to the sulfur and nitrogen heteroatoms were compared to 13C NMR data from model compounds. This allowed for the determination of these heteroatoms' locations in the ring, and subsequently the existence of the thiazoline ring itself. [8] With these partial structures established, their connectivity was evaluated via HMBC spectroscopy, [4] a 2D NMR technique which allows for the determination of heteronuclear J-coupling values for nonadjacent carbons and protons. This allows for the spatial relation of specific carbon and hydrogen atoms within a structure to be determined.

Stereochemistry

Kalkitoxin has five chiral centers, one of which is the ring carbon to which the terminal alkene is coordinated, with the remaining four occurring at tertiary carbon atoms along the aliphatic chain originating from the imine nitrogen. The total stereochemistry of natural (+)-kalkitoxin is 3R,7R,8S,10S,2′R. [6] For this determination, 3JCH values by a variation of the HSQMBC pulse technique, a type of HMBC spectroscopy, and 3JHH values by exclusive correlation spectroscopy (E.COSY). These methods use NMR to evaluate the spin-spin coupling constants which directly relate to the dihedral angle of the atoms being analyzed, allowing for the determination of chirality. This was used to determine the stereochemistry of chiral centers at C7, C8, and C10. Because C7 and C8 are adjacent stereocenters, these techniques allowed for immediate determination of their relative stereochemistry, however C10 is separated from C8 by C9, which carries two diastereotopic protons. This allows for the determination of relative stereochemistry of C8 and C10 to the C9 protons through [[J-coupling \ 3J coupling]] values, so as to relate the relative stereochemistry of C8 to C10. These methods yielded a relative stereochemistry of 7R, 8S, 10S for the aliphatic chain stereocenters. [6] Stereochemistry at C3 was determined by Marfey's analysis, wherein the compound was ozonized and subsequently hydrolyzed to obtain cysteic acid from the thiazoline ring and attached terminal alkene. Marfey's analysis indicated this amino acid derivative was L-cysteic acid, indicating R absolute stereochemistry at C3. [6] The absolute stereochemistry of the total molecule was determined by synthesizing the possible configurations of the already determined relative chiralities, and comparison of these to natural Kalkitoxin via 13C NMR shift differences, revealing the natural (+)-kalkitoxin stereochemistry to be 3R,7R,8S,10S,2′R. [6]

Structure-activity relationship

The structure-activity relationship (SAR) of a molecule is the connection between the structural moieties within the compound, and how those specific structures directly contribute to the extent and character of the molecule's biological activity. Kalkitoxin exhibits potent cytotoxicity which relies on the complete thiazoline ring for its action. [9] Kalkitoxin analogs lacking the complete thiazoline ring exhibit on the order of 1000-fold decreased toxicity to solid tumor cell lines. [9] This indicates the thiazoline ring structure is a crucial component of kalkitoxin's mechanism of cytotoxicity. The necessity of the stereochemistry exhibited in natural (+)-kalkitoxin decreases moving towards the chiral centers in the core of the molecule, while the more terminal chiral centers and amide methyl group are increasingly crucial for toxicity. [7] In a study which assayed for the toxicity of kalkitoxin and various analogs against brine shrimp, the analogs which experienced the least significant loss of potency were epimers at either C8 or C10. [7] This indicates that C8 and C10 chiralities in natural (+)-kalkitoxin are the least critical for toxic biological activity. It is apparent that C10 chirality is less critical than C8, because the epimer of (+)-kalkitoxin at C10 is more potent than the epimer at C8. [7] Furthermore, the removal of the C10 methyl group has a smaller impact on potency than does epimerization of C7, supporting the trend of decreased SAR correlation at core chiral centers on the aliphatic chain. [7] Epimerization at C3, the attachment point of the terminal alkene to the thiazoline ring, further decreases potency of kalkitoxin, in agreement with the thiazoline ring and overall conformation of the leftmost segment of the molecule being critical for bioactivity. Finally, replacement of the tertiary amide with a secondary amide eliminates any observable toxicity, so this structure is crucial in the mechanism of kalkitoxin toxicity. [7]

Synthesis

Wu et al. synthesis

This effort was the first total synthesis of (+)-kalkitoxin, and served the purpose of deducing the specific stereochemistry of natural kalkitoxin. [6] This synthesis began from an alcohol bearing the proper chirality at C8 and C10 found in (+)-kalkitoxin, and carried a dimethylphenylsiloxy (DPSO) group positioned beta to C8, and a terminal alkene positioned alpha to C10. Hydroboration of this alkene gives the resulting alcohol, which is converted to an azide, which is the position at which (R)-2-methylbutyric acid is coupled to produce the sec-butyl group and amide group. The amide is subsequently methylated, finalizing the tertiary amide which has been shown to be so crucial for kalkitoxin toxicity. [7] O-Desilylation and oxidation of the resulting alcohol produce an acceptor for a Horner-Wadsworth-Emmons reaction, wherein a carbonyl and an alpha-methylated phosphonate react to produce an alkene. In this case, a beta-keto phosphonate bearing an (R)-phenylglycine-derived auxiliary group was ligated to the molecule. This group is lost in asymmetric conjugate addition of an (R)-amino alcohol, which, through two cyclodehydration steps using Wipf's oxazoline-thiazoline interconversion protocol, produces the thiazoline ring. [6]

White et al. synthesis

The second total synthesis of (+)-kalkitoxin was only 16 steps and gave a 3% overall yield. [10] A major aspect by which this differs from the first total synthesis of (+)-kalkitoxin is that rather than using a Horner-Wadsworth-Emmons reaction to ligate a phosphonate carrying the 4-phenyl-2-oxazolidinone, an organocopper conjugate addition reaction was used instead. [10] This was done specifically by connecting the organocopper species to a 4-phenyl-2-oxazolidinone carrying an (S)-N-trans-crotonyl group through a 1,4-nucleophilic addition to the α,β-unsaturation of the crotonyl group. This method is advantageous because it allows for stereoselectivity of the resulting 1,3-dimethyl configuration during the larger sequential introduction of the methyl substituents at the C7, C8 and C10 chiral centers.

Another point of diversion between these two syntheses is the number of carbons separating the keto-auxiliary group from the chiral center at C7. This group was separated by one carbon from C7 in the first total synthesis, so the keto-auxiliary moiety could be converted to a carboxylic acid, in anticipation of addition of the amino alcohol immediately thereafter. [6] In this synthesis, this keto-auxiliary group is directly adjacent to C7, necessitating a one carbon homologation, before construction of the thiazoline ring. This was achieved through reductive bond cleavage of the auxiliary group to a primary alcohol and oxidation to the corresponding aldehyde, Wittig reaction using an ylide carrying a methoxy group to produce an enol ether, hydrolysis to the aldehyde and finally oxidation to produce the carboxylic acid. [10]

Balieu et al. synthesis

This synthesis differentiates itself in that it takes an "assembly line" synthesis approach, as opposed to the conventional iterative synthetic approach taken in previous syntheses which normally necessitate functional-group interconversions and repetitive purifications for aliphatic chain extensions, such as the one found in kalkitoxin. This novel approach is achieved through the use of reagent-controlled chain extension of a boronic ester, [11] which relies on a spontaneous 1,2-migration after formation of an intermediate compound incorporating a newly added lithiated benzoate ester building block. [12]

This allows for control of chirality at each addition by selecting the chirality of each benzoate ester added. Furthermore, this avoids repetitive interconversion and purification steps normally required for repeat chain extensions, which increases yield and efficiency and decreases labor. This synthesis capitalized on this technique by producing the core aliphatic chain as a single large fragment, and coupled this fragment to the chiral sec-butyl group bearing a carboxylic acid. [12] The opposing amino thioether fragment was synthesized separately, and then adjoined and subsequently cyclized following the procedure devised by White et al. [10] In total, this synthesis requires only 7 steps if the initial homologation series is counted as one step. [12]

Published on Nature : Burns, M., Essafi, S., Bame, J. et al. Assembly-line synthesis of organic molecules with tailored shapes. Nature 513, 183–188 (2014). https://doi.org/10.1038/nature13711

Targets

Kalkitoxin may activate the NMDA receptor. [1] It also blocks the voltage-gated sodium channel [13] and the electron transport chain (ETC) complex 1. [13] It remains unknown how exactly kalkitoxin binds to the voltage-gated sodium channel. Neurotoxin sit 1 and 2 have been ruled out as possible binding sites, whereas neurotoxin site 7 is suggested as binding site for kalkitoxin. [4] This is probable, because there is inhibition of the channel by kalkitoxin when deltamethrin, which has positive allosteric effects, is present. [13] This could be because molecular determinants for binding are similar in kalkitoxin and deltamethrin. [13]

Mode of action

This figure illustrates the two distinct interactions kalkitoxin makes with receptors in the glutamatergic synapse, and how these two interactions are oppositional at the level of neuronal survival. Kalkitoxin Opposing Mechanisms of Neurotoxicity.jpg
This figure illustrates the two distinct interactions kalkitoxin makes with receptors in the glutamatergic synapse, and how these two interactions are oppositional at the level of neuronal survival.

Kalkitoxin induces delayed neuronal necrosis in cerebellar granule cells of the rat. [1] This neuronal necrosis proved to be NMDA-receptor mediated. [1] These receptors are normally activated by glutamate and other excitotoxic compounds and can induce neuronal necrosis. [1] It is not yet known if the toxin induces necrosis directly or via the release of excitotoxic compounds. [1]

Secondly, kalkitoxin blocks voltage-gated sodium channels, thereby inhibiting Ca2+ release that normally occurs when the voltage-gated sodium channel is activated, in a concentration dependent matter. [13] Calcium release has been shown to induce lactate dehydrogenase (LDH) production. [13] The amount of LDH is a measure for neuronal cell death. [13] In the presence of kalkitoxin there is also a concentration-dependent inhibition of neuronal cell death and LDH production (9). The mechanism behind this inhibition is still unknown. [13]

Thirdly, kalkitoxin blocks the electron transport chain (ETC) complex 1, [2] one of the protein complexes involved in mitochondrial respiration. [2] By blocking the ETC complex 1, kalkitoxin potently inhibits hypoxia-inducible factor-1 (HIF-1) activation. [2] HIF-1 is a transcription factor, which enhances the expression of genes that increase oxygen availability, as well as genes that decrease oxygen consumption. [2] Inhibition of HIF-1, which is one of the main effects of kalkitoxin, thus induces cellular hypoxia.

Toxicity

Kalkitoxin is ichthyotoxic to goldfish ( Carassius auratus , LC50: 700nM) and to aquatic crustacean brine shrimp ( Artemia salina , LC50: 150-180nM [7] ). [14] Kalkitoxin also has been shown to have delayed neurotoxic effects on cerebellar granule cells of the rat (LC50: 3,86nM). [2]

Therapeutic research

Many efforts to discover cancer therapeutic drugs focus on the screening of novel biomolecules produced and isolated from various plants and animals. [15] These isolated molecules are screened via in-vitro assays to measure their effects in standardized paradigms designed to select for the desired therapeutic effect. Kalkitoxin was originally isolated from Lyngbya majuscula as an effort to collect new molecules for testing as antitumor or antifungal agents. [4] One of the first tests of kalkitoxin tumor-selective cytotoxicity used an in-vitro assay to test solid tumor selectivity of kalkitoxin's previously demonstrated cytotoxicity against the human colon cell line HCT-116. [9] The assay measured the extent of differential cytotoxicity of kalkitoxin and various analogous structures by observing differential cytotoxicity against solid tumor cells, and either non-solid tumor cells such as leukemia cells or normal cells. This test yielded promising results, as kalkitoxin exhibited preferential cytotoxicity for the solid tumor cell test conditions (Colon 38, and HCT-116 cells) as compared to the non-solid tumor and normal cell conditions. [9]

Kalkitoxin exerts this cytotoxic effect through inhibition of the mitochondrial electron transport chain complex 1. [2] This causes the inhibition of hypoxia-induced HIF-1 activation, which is crucial in solid tumor cancers because hypoxia drives tumor angiogenesis, leading to worsening disease stages and increased resistance to treatment. HIF-1 is a transcription factor which induces expression of genes promoting oxygen availability and decreasing oxygen consumption, the effect of which counteracts cellular hypoxia. [16] Therefore, kalkitoxin's HIF-1 inhibitory ability positions it as a potentially promising molecule to counteract the progression of some solid tumor cancers by blocking the tumor proliferative response to hypoxia. The caveat to kalkitoxin's promising anti-proliferative properties is its neurotoxic effects. At concentrations comparable to those required for tumor-selective cytotoxicity, kalkitoxin induces cell death when applied to rat cerebellar granule neurons (CGN) in culture. [2] Kalkitoxin acts as an N-methyl-D-aspartate (NMDA) receptor agonist, and induces cytotoxicity in cultured rat CGNs at delayed time points. [1] Therefore, this effect must be taken into account when considering kalkitoxin or its chemical derivatives for use as a therapeutic option.

Related Research Articles

<span class="mw-page-title-main">Alkene</span> Hydrocarbon compound containing one or more C=C bonds

In organic chemistry, an alkene, or olefin, is a hydrocarbon containing a carbon–carbon double bond. The double bond may be internal or in the terminal position. Terminal alkenes are also known as α-olefins.

<span class="mw-page-title-main">Ene reaction</span> Reaction in organic chemistry

In organic chemistry, the ene reaction is a chemical reaction between an alkene with an allylic hydrogen and a compound containing a multiple bond, in order to form a new σ-bond with migration of the ene double bond and 1,5 hydrogen shift. The product is a substituted alkene with the double bond shifted to the allylic position.

<span class="mw-page-title-main">Chiral auxiliary</span> Stereogenic group placed on a molecule to encourage stereoselectivity in reactions

In stereochemistry, a chiral auxiliary is a stereogenic group or unit that is temporarily incorporated into an organic compound in order to control the stereochemical outcome of the synthesis. The chirality present in the auxiliary can bias the stereoselectivity of one or more subsequent reactions. The auxiliary can then be typically recovered for future use.

<span class="mw-page-title-main">Cyclic compound</span> Molecule with a ring of bonded atoms

A cyclic compound is a term for a compound in the field of chemistry in which one or more series of atoms in the compound is connected to form a ring. Rings may vary in size from three to many atoms, and include examples where all the atoms are carbon, none of the atoms are carbon, or where both carbon and non-carbon atoms are present. Depending on the ring size, the bond order of the individual links between ring atoms, and their arrangements within the rings, carbocyclic and heterocyclic compounds may be aromatic or non-aromatic; in the latter case, they may vary from being fully saturated to having varying numbers of multiple bonds between the ring atoms. Because of the tremendous diversity allowed, in combination, by the valences of common atoms and their ability to form rings, the number of possible cyclic structures, even of small size numbers in the many billions.

<span class="mw-page-title-main">Asymmetric induction</span> Preferential formation of one chiral isomer over another in a chemical reaction

Asymmetric induction describes the preferential formation in a chemical reaction of one enantiomer or diastereoisomer over the other as a result of the influence of a chiral feature present in the substrate, reagent, catalyst or environment. Asymmetric induction is a key element in asymmetric synthesis.

In stereochemistry, topicity is the stereochemical relationship between substituents and the structure to which they are attached. Depending on the relationship, such groups can be heterotopic, homotopic, enantiotopic, or diastereotopic.

<span class="mw-page-title-main">Kuwajima Taxol total synthesis</span>

The Kuwajima Taxol total synthesis by the group of Isao Kuwajima of the Tokyo Institute of Technology is one of several efforts in taxol total synthesis published in the 1990s. The total synthesis of Taxol is considered a landmark in organic synthesis.

<span class="mw-page-title-main">Spirotryprostatin B</span> Chemical compound

Spirotryprostatin B is an indolic alkaloid found in the Aspergillus fumigatus fungus that belongs to a class of naturally occurring 2,5-diketopiperazines. Spirotryprostatin B and several other indolic alkaloids have been found to have anti-mitotic properties, and as such they have become of great interest as anti-cancer drugs. Because of this, the total syntheses of these compounds is a major pursuit of organic chemists, and a number of different syntheses have been published in the chemical literature.

<span class="mw-page-title-main">Mukaiyama Taxol total synthesis</span>

The Mukaiyama taxol total synthesis published by the group of Teruaki Mukaiyama of the Tokyo University of Science between 1997 and 1999 was the 6th successful taxol total synthesis. The total synthesis of Taxol is considered a hallmark in organic synthesis.

<span class="mw-page-title-main">EGLN1</span> Protein-coding gene in the species Homo sapiens

Hypoxia-inducible factor prolyl hydroxylase 2 (HIF-PH2), or prolyl hydroxylase domain-containing protein 2 (PHD2), is an enzyme encoded by the EGLN1 gene. It is also known as Egl nine homolog 1. PHD2 is a α-ketoglutarate/2-oxoglutarate-dependent hydroxylase, a superfamily non-haem iron-containing proteins. In humans, PHD2 is one of the three isoforms of hypoxia-inducible factor-proline dioxygenase, which is also known as HIF prolyl-hydroxylase.

<span class="mw-page-title-main">Apratoxin A</span> Chemical compound

Apratoxin A - is a cyanobacterial secondary metabolite, known as a potent cytotoxic marine natural product. It is a derivative of the Apratoxin family of cytotoxins. The mixed peptide-polyketide natural product comes from a polyketide synthase/non-ribosomal peptide synthase pathway (PKS/NRPS). This cytotoxin is known for inducing G1-phase cell cycle arrest and apoptosis. This natural product's activity has made it a popular target for developing anticancer derivatives.

<span class="mw-page-title-main">Enders SAMP/RAMP hydrazone-alkylation reaction</span>

The Enders SAMP/RAMP hydrazone alkylation reaction is an asymmetric carbon-carbon bond formation reaction facilitated by pyrrolidine chiral auxiliaries. It was pioneered by E. J. Corey and D. Enders in 1976, and was further developed by D. Enders and his group. This method is usually a three-step sequence. The first step is to form the hydrazone between (S)-1-amino-2-methoxymethylpyrrolidine (SAMP) or (R)-1-amino-2-methoxymethylpyrrolidine (RAMP) and a ketone or aldehyde. Afterwards, the hydrazone is deprotonated by lithium diisopropylamide (LDA) to form an azaenolate, which reacts with alkyl halides or other suitable electrophiles to give alkylated hydrazone species with the simultaneous generation of a new chiral center. Finally, the alkylated ketone or aldehyde can be regenerated by ozonolysis or hydrolysis.

<span class="mw-page-title-main">Hectochlorin</span> Chemical compound

Hectochlorin is a lipopeptide that exhibits potent antifungal activity against C. albicans and a number of plants pathogens, as well as inhibiting growth of human cell lines by hyperpolymerization of actin. It was originally isolated from the filamentous cyanobacterium Moorea producens JHB, collected from Hector Bay, Jamaica, 1996, which is a strain also known for being the producer of other two potent biomolecules named Jamaicamide A and Cryptomaldamide. Due to its activity against plants pathogens, synthetic efforts elucidated the compound’s total synthesis in 2002. Moorea species are normally the main component of the dietary of some sea hares, which concentrate the cyanobacterial metabolites as a mechanism of defense from predators. Therefore, in 2005, hectochlorin was re-isolated from the Thai sea hare Bursatella leachii, along with a new analogue, deacetylhectochlorin. Another reisolation of hectochlorin was reported in 2013, from another Moorea producens strain (RS05), isolated from the Red Sea, surprising in a non-tropical environment, as opposed to the other Moorea strains isolated before. The predicted biosynthesis of hectochlorin was published in 2007 and consists in a hybrid NRPS-PKS, with a hexanoic acid as start unit that becomes halogenated twice in the position 5, producing fairly rare gem-dichloro group, that along with two 2,3-dihydroxyisovaleric acid (DHIV) units compose a very interesting bioactive molecule.

<span class="mw-page-title-main">Kedarcidin</span> Chemical compound

Kedarcidin is a chromoprotein antitumor antibiotic first isolated from an Actinomycete in 1992, comprising an ansa-bridged enediyne chromophore (shown) as well as an apoprotein that serves to stabilize the toxin in the Actinomycete. Like other members of the enediyne class of drugs—so named for the nine-or-ten-membered core structure bearing an alkene directly attached to two alkynyl appendages—kedarcidin was likely evolved to kill bacteria that compete with the producing organism. Because it achieves this by causing DNA damage, however, kedarcidin is capable of harming tumor cells, as well. Kedarcidin is thus the subject of scientific research, both for its structural complexity as well as its anticancer properties.

The [4+4] Photocycloaddition is a cycloaddition reaction in which two unsaturated molecules connect via four atoms from each molecule to create an eight-membered ring. As a photochemical reaction, it is promoted by some form of light, as opposed to a thermal process.

Curacin A is a hybrid polyketide synthase (PKS)/nonribosomal peptide synthase (NRPS) derived natural product produced isolated from the cyanobacterium Lyngbya majuscula. Curacin A belongs to a family of natural products including jamaicamide, mupirocin, and pederin that have an unusual terminal alkene. Additionally, Curacin A contains a notable thiazoline ring and a unique cyclopropyl moiety, which is essential to the compound's biological activity. Curacin A has been characterized as potent antiproliferative cytotoxic compound with notable anticancer activity for several cancer lines including renal, colon, and breast cancer. Curacin A has been shown to interact with colchicine binding sites on tubulin, which inhibits microtubule polymerization, an essential process for cell division and proliferation.

<span class="mw-page-title-main">Antillatoxin</span> Chemical compound

Antillatoxin (ATX) is a potent lipopeptide neurotoxin produced by the marine cyanobacterium Lyngbya majuscula. ATX activates voltage-gated sodium channels, which can cause cell depolarisation, NMDA-receptor overactivity, excess calcium influx and neuronal necrosis.

<span class="mw-page-title-main">Debromoaplysiatoxin</span> Chemical compound

Debromoaplysiatoxin is a toxic agent produced by the blue-green alga Lyngbya majuscula. This alga lives in marine waters and causes seaweed dermatitis. Furthermore, it is a tumor promoter which has an anti-proliferative activity against various cancer cell lines in mice.

<span class="mw-page-title-main">Hoiamides</span> Chemical compound

The hoiamides are a class of small molecules recently characterized from isolations of secondary metabolites of cyanobacteria that feature a triheterocyclic system. Hoiamide A and B are cyclic while hoiamide C and D are linear. Hoiamide A and B demonstrate neurotoxicity by acting on mammalian voltage gated sodium channels, while hoiamide D shows inhibition of the p53/MDM2 complex. The hoiamides are promising therapeutic targets, making their total synthesis an attractive feat.

<span class="mw-page-title-main">Lyngbyastatins</span> Chemical compound

Lyngbyastatins 1 and 3 are cytotoxic cyclic depsipeptides that possess antiproliferative activity against human cancer cell lines. These compounds, first isolated from the extract of a Lyngbya majuscula/Schizothrix calcicola assemblage and from L. majuscula Harvey ex Gomont (Oscillatoriaceae) strains, respectively, target the actin cytoskeleton of eukaryotic cells.

References

  1. 1 2 3 4 5 6 7 8 9 Berman; et al. (1999). "Antillatoxin and kalkitoxin, ichthyotoxins from the tropical cyanobacterium Lyngbya majuscula, induce distinct temporal patterns of NMDA receptor-mediated neurotoxicity". Toxicon. 37 (11): 1645–8. doi:10.1016/s0041-0101(99)00108-7. PMID   10482399.
  2. 1 2 3 4 5 6 7 8 9 Morgan; et al. (2015). "Kalkitoxin inhibits angiogenesis, disrupts cellular hypoxic signaling and blocks mitochondrial electron transport in tumor cells". Marine Drugs. 13 (3): 1552–1568. doi: 10.3390/md13031552 . PMC   4377999 . PMID   25803180.
  3. ↑ Nogle and Gerwick (2003). "Diverse Secondary Metabolites from a Puerto Rican Collection of Lyngbya Majuscula". Journal of Natural Products. 66 (2): 217–20. doi:10.1021/np020332c. PMID   12608852.
  4. 1 2 3 4 5 6 Wu, M. (1997). Novel bioactive secondary metabolites from the marine cyanobacterium Lyngbya majuscule, Thesis (M.S.). Oregon State University.
  5. ↑ Royal Society of Chemistry 2015. "ChemSpider Kalkitoxin".{{cite web}}: CS1 maint: numeric names: authors list (link)
  6. 1 2 3 4 5 6 7 8 9 10 Wu; et al. (2000). "Structure, Synthesis, and Biological Properties of Kalkitoxin, a Novel Neurotoxin from the Marine Cyanobacterium Lyngbya majuscule". Journal of the American Chemical Society. 122 (48): 12041–12042. doi:10.1021/ja005526y.
  7. 1 2 3 4 5 6 7 8 9 Umezawa; et al. (2011). "Synthesis and Biological Activity of Kalkitoxin and its Analogues". Journal of Organic Chemistry. 77 (1): 357–70. doi:10.1021/jo201951s. PMID   22111947.
  8. ↑ Hawkins, Clifford J.; Lavin, Martin F.; MarshallKaren A., Karen A.; Van den Brenk, Anna L.; Watters, Diane J. (1990-06-01). "Structure-activity relationships of the lissoclinamides: cytotoxic cyclic peptides from the ascidian Lissoclinum patella". Journal of Medicinal Chemistry. 33 (6): 1634–1638. doi:10.1021/jm00168a016. PMID   2342056.
  9. 1 2 3 4 White, James D.; Xu, Qing; Lee, Chang-Sun; Valeriote, Frederick A (2004). "Total synthesis and biological evaluation of (+)-kalkitoxin, a cytotoxic metabolite of the cyanobacterium Lyngbya majuscula". Organic & Biomolecular Chemistry. 2 (14): 2092–2102. doi:10.1039/B404205K. PMID   15254638.
  10. 1 2 3 4 White, James D; Lee, Chang-Sun; Xu, Qing (2003). "Total synthesis of (+)-kalkitoxin". Chemical Communications (16): 2012–2013. doi:10.1039/B306124H. PMID   12934887.
  11. ↑ Burns; et al. (2014). "High Precision Assembly Line Synthesis for Molecules with Tailored Shapes". Nature. 513 (7517): 183–188. doi:10.1038/nature13711. PMC   4167605 . PMID   25209797.
  12. 1 2 3 Balieu; et al. (2015). "Toward Ideality: The Synthesis of (+)-Kalkitoxin and (+)-Hydroxyphthioceranic Acid by Assembly-Line Synthesis". Journal of the American Chemical Society. 137 (13): 4398–4403. doi:10.1021/ja512875g. PMID   25625684.
  13. 1 2 3 4 5 6 7 8 LePage; et al. (2005). "The neurotoxic lipopeptide kalkitoxin interacts with voltage-sensitive sodium channels in cerebellar granule neurons". Toxicology Letters. 158 (2): 133–9. doi:10.1016/j.toxlet.2005.03.007. PMID   16039402.
  14. ↑ Sarma, T.A. (2012). Handbook of Cyanobacteria. CRC Press. p. 539. ISBN   9781578088003.
  15. ↑ de Bono; et al. (2003). "The future of cytotoxic therapy: selective cytotoxicity based on biology is the key". Breast Cancer Research. 5 (3): 154–9. doi: 10.1186/bcr597 . PMC   165009 . PMID   12793897.
  16. ↑ Semenza, G.L. Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu. Rev. Pathol. 2014, 9, 47–71.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.